宫颈滋养层细胞提取与分离:宫颈滋养层细胞的来源及其对持续妊娠风险评估的潜在价值
本文综述了宫颈滋养层细胞提取与分离(TRIC)技术的来源与可能用途,该技术可在妊娠5-20周通过巴氏涂片获取宫颈中的绒毛外滋养层(EVT)细胞。分离的细胞含胎儿基因组且呈EVT样表达谱,可用于胚胎/胎儿基因分型,其生物标志物蛋白表达与后续妊娠丢失、子痫前期和胎儿生长受限相关。
要点
- TRIC可从妊娠5-20周巴氏涂片分离宫颈EVT细胞,纯度>95% β-hCG阳性。
- 分离细胞含胎儿基因组,可用靶向二代测序准确进行胚胎/胎儿基因分型。
- 宫颈滋养层细胞生物标志物蛋白表达与后续妊娠丢失、子痫前期和胎儿生长受限相关。
核心结论
- TRIC有朝一日可提供母胎疾病风险评估方法,并揭示与胎盘发育异常相关的早孕期EVT细胞分子通路紊乱。
- 随着针对妊娠疾病和遗传性先天疾病的围产期干预出现,TRIC可能成为产科个性化精准医疗的关键诊断工具。
研究设计与样本
- 本综述通过检索PubMed和Google Scholar数据库,纳入1966年至2017年间发表的80篇文献中的52篇,并结合宫内胎盘组织学切片证据。
- 研究描述了滋养层侵入子宫血管和腺体以及存在于生殖道中的滋养层细胞,并补充了人类胎盘健康与疾病相关文献。
主要发现
- 自20世纪70年代以来,研究者尝试从子宫或宫颈回收滋养层细胞用于产前诊断。
- 妊娠5-20周巴氏涂片中的滋养层细胞通过抗HLA-G纳米颗粒免疫磁珠分离(TRIC)纯化,纯度>95% β-hCG阳性。
- 分离细胞含胎儿基因组并呈EVT样表达谱,类似EVT细胞见于子宫腺体腔并沿胎盘边缘进入子宫腔,提示其为宫颈滋养层细胞的主要来源。
- TRIC分离细胞可通过靶向二代测序准确进行胚胎/胎儿基因分型。
- 宫颈滋养层细胞中生物标志物蛋白表达量化与后续妊娠丢失、子痫前期和胎儿生长受限相关。
关键数值与推荐
- TRIC分离的宫颈滋养层细胞纯度>95% β-hCG阳性。
- 宫颈滋养层细胞生物标志物蛋白表达与后续妊娠丢失、子痫前期和胎儿生长受限相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 一个关键未解问题是宫颈EVT细胞与基底板和胎盘床EVT细胞之间的差异程度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early during human development, the trophoblast lineage differentiates to commence placentation. Where the placenta contacts the uterine decidua, extravillous trophoblast (EVT) cells differentiate and invade maternal tissues. EVT cells, identified by expression of HLA-G, invade into uterine blood vessels (endovascular EVT), as well as glands (endoglandular EVT), and open such luminal structures towards the intervillous space of the placenta. Endoglandular invasion diverts the contents of uterine glands to the intervillous space, while glands near the margin of the placenta that also contain endoglandular EVT cells open into the reproductive tract. Cells of the trophoblast lineage have thus been recovered from the uterine cavity and endocervical canal. An emerging non-invasive technology [trophoblast retrieval and isolation from the cervix (TRIC)] isolates and examines EVT cells residing in the cervix to explore their origin, biology and relationship to pregnancy and fetal status. OBJECTIVE AND RATIONALE: This review explores the origins and possible uses of trophoblast cells obtained during ongoing pregnancies (weeks 5-20) by TRIC. We hypothesize that endoglandular EVT cells at the margins of the expanding placenta enter the uterine cavity and are carried together with uterine secretion products to the cervix where they can be retrieved from a Papanicolaou (Pap) smear. The advantages of TRIC for investigation of human placentation and prenatal testing will be considered. Evidence from the literature, and from archived in utero placental histological sections, is presented to support these hypotheses. SEARCH METHODS: We used 52 out of 80 publications that appeared between 1966 and 2017 and were found by searching the PubMed and Google Scholar databases. The studies described trophoblast invasion of uterine vessels and glands, as well as trophoblast cells residing in the reproductive tract. This was supplemented with literature on human placental health and disease. OUTCOMES: The literature describes a variety of invasive routes taken by EVT cells at the fetal-maternal interface that could displace them into the reproductive tract. Since the 1970s, investigators have attempted to recover trophoblast cells from the uterus or cervix for prenatal diagnostics. Trophoblast cells from Pap smears obtained at 5-20 weeks of gestation have been purified (>95% β-hCG positive) by immunomagnetic isolation with nanoparticles linked to anti-HLA-G (TRIC). The isolated cells contain the fetal genome, and have an EVT-like expression profile. Similar EVT-like cells appear in the lumen of uterine glands and can be observed entering the uterine cavity along the margins of the placenta, suggesting that they are the primary source of cervical trophoblast cells. Cells isolated by TRIC can be used to accurately genotype the embryo/fetus by targeted next-generation sequencing. Biomarker protein expression quantified in cervical trophoblast cells after TRIC correlates with subsequent pregnancy loss, pre-eclampsia and fetal growth restriction. A key remaining question is the degree to which EVT cells in the cervix might differ from those in the basal plate and placental bed. WIDER IMPLICATIONS: TRIC could one day provide a method of risk assessment for maternal and fetal disease, and reveal molecular pathways disrupted during the first trimester in EVT cells associated with placental maldevelopment. As perinatal interventions emerge for pregnancy disorders and inherited congenital disorders, TRIC could provide a key diagnostic tool for personalized precision medicine in obstetrics.
引用
- Moser G, Drewlo S, Huppertz B, et al. Trophoblast retrieval and isolation from the cervix: origins of cervical trophoblasts and their potential value for risk assessment of ongoing pregnancies. Hum Reprod Update. 2018. PMID: 29608700. doi:10.1093/humupd/dmy008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。